Additional file 3 of Survival benefit of ixazomib, lenalidomide and dexamethasone (IRD) over lenalidomide and dexamethasone (Rd) in relapsed and refractory multiple myeloma patients in routine clinical practice
收藏NIAID Data Ecosystem2026-03-12 收录
数据链接：
官方服务：
资源简介：
Additional file 3: Supplementary Table 3a. Association of ORR with selected variables. Supplementary Table 3b Association of ORR with selected variables in multivariable analysis – Paired analysis.
创建时间：
2021-01-15
